| Vladimir Alhov, MD | |
|
3805 Nazareth Pike, Bethlehem, PA 18020-1140 | |
| (866) 734-2202 | |
| Not Available |
| Full Name | Vladimir Alhov |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 39 Years |
| Location | 3805 Nazareth Pike, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083681738 | NPI | - | NPPES |
| Entity Name | Vladimir Alhov Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336320910 PECOS PAC ID: 5991761280 Enrollment ID: O20041208000704 |
News Archive
Compugen Ltd. announced today the development of its Protein-Protein Interaction Blockers (PPI Blockers) Discovery Platform, designed for the prediction of peptides to block disease associated protein-protein interactions. In a pilot validation run, predicted peptides showed positive results for drug targets in two cancer related pathways of interest to the industry.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of TRX518, a monoclonal antibody designed to enhance the immune system by enabling T cells to more effectively attack cancer cells.
The tiny thymus teaches the immune system to ignore the teeming, foreign bacteria in the gut that helps you digest and absorb food, researchers say.
Babita Adhikari Dhungel, doctoral student in biology from Nepal, is researching the cause of CLN8 disease, which is a form of neuronal ceroid lipofuscinoses.
Scientists from the Baylor College of Medicine Human Genome Sequencing Center (HGSC) are expanding their fleet of advanced genomic next-generation sequencing technology from Applied Biosystems, part of Life Technologies Corporation to accelerate their studies of the genetic underpinnings of cancer and other complex human diseases.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vladimir Alhov, MD 80 Avenue P, Apt. D6, Brooklyn, NY 11204-6101 Ph: () - | Vladimir Alhov, MD 3805 Nazareth Pike, Bethlehem, PA 18020-1140 Ph: (866) 734-2202 |
News Archive
Compugen Ltd. announced today the development of its Protein-Protein Interaction Blockers (PPI Blockers) Discovery Platform, designed for the prediction of peptides to block disease associated protein-protein interactions. In a pilot validation run, predicted peptides showed positive results for drug targets in two cancer related pathways of interest to the industry.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of TRX518, a monoclonal antibody designed to enhance the immune system by enabling T cells to more effectively attack cancer cells.
The tiny thymus teaches the immune system to ignore the teeming, foreign bacteria in the gut that helps you digest and absorb food, researchers say.
Babita Adhikari Dhungel, doctoral student in biology from Nepal, is researching the cause of CLN8 disease, which is a form of neuronal ceroid lipofuscinoses.
Scientists from the Baylor College of Medicine Human Genome Sequencing Center (HGSC) are expanding their fleet of advanced genomic next-generation sequencing technology from Applied Biosystems, part of Life Technologies Corporation to accelerate their studies of the genetic underpinnings of cancer and other complex human diseases.
› Verified 9 days ago
Sydney Wright, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 866-785-8537 | |
Dr. Brian Keith Goldberg, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 2775 Schoenersville Rd, Bethlehem, PA 18017 Phone: 610-861-8080 Fax: 610-807-0366 | |
Ashley De Padua, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1417 8th Ave, Bethlehem, PA 18018 Phone: 484-526-5210 Fax: 866-568-6561 | |
Dr. Debra Ibrahim, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2775 Schoenersville Rd, Bethlehem, PA 18017 Phone: 877-247-8080 | |
Dr. Troy Robert Wood, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2775 Schoenersville Rd, Bethlehem, PA 18017 Phone: 610-861-8080 | |
Wayne E Dubov, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1770 Bathgate Rd, Suite 402, Bethlehem, PA 18017 Phone: 610-402-3560 Fax: 610-402-3355 |